Skip to contentS
SeaStar Medical Holding Corp
S
ICUCWSeaStar Medical Holding Corp Q2 2024 · 10-Q
Revenue$0.00$0.00no prior Q2 2023 on file Net Income-$3.24M-$3.24MN/M vs Q2 2023 EPS Diluted-$1.03-$1.03N/M vs Q2 2023 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SeaStar Medical Holding Corp · CIK 1831868 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,824,000N/M ended Jun 30, 2024 · filed Aug 13, 2024 · 44 d after period end